menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro

2 0
31.10.2025
Eli Lilly reported stellar third-quarter earnings yesterday and raised this year’s revenue estimates from $60 billion–$62 billion to $63 billion–$63.5 billion.

© Fortune